نتائج البحث - "Bastian von Tresckow"

1

Reinduction therapy with everolimus in combination with dexamethasone, high‐dose cytarabin and cisplatinum in patients with relapsed or refractory classical Hodgkin lymphoma: an experimental phase I/II multicentre trial of the German Hodgkin Study Group (GHSG HD‐R3i)

المصدر: British Journal of Haematology. 196:606-616

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff0e354fe4bdc404cc0b06b20f948d15Test
https://doi.org/10.1111/bjh.17878Test

2

Effectiveness of brentuximab vedotin monotherapy in relapsed or refractory Hodgkin lymphoma: a systematic review and meta-analysis

المؤلفون: Aurore Bergamasco, Yola Moride, Wouter J. Plattel, F. Trinchese, Athanasios Zomas, Nawal Bent-Ennakhil, Genaro Castillon, Teigna Arredondo-Bisono, Bastian von Tresckow, François Gavini, Tiffany Cristarella

المصدر: Leukemia & Lymphoma. 62:3320-3332

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20ae549228bb5472cb72128bf4a2c02aTest
https://doi.org/10.1080/10428194.2021.1957865Test

3

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

المساهمون: Hematology, CCA - Imaging and biomarkers, CCA - Cancer Treatment and quality of life

المصدر: The Lancet Oncology, 22(2), 223-234. Lancet Publishing Group
Borchmann, P, Plütschow, A, Kobe, C, Greil, R, Meissner, J, Topp, M S, Ostermann, H, Dierlamm, J, Mohm, J, Thiemer, J, Sökler, M, Kerkhoff, A, Ahlborn, M, Halbsguth, T V, Martin, S, Keller, U, Balabanov, S, Pabst, T, Vogelhuber, M, Hüttmann, A, Wilhelm, M, Zijlstra, J M, Moccia, A, Kuhnert, G, Bröckelmann, P J, von Tresckow, B, Fuchs, M, Klimm, B, Rosenwald, A, Eich, H, Baues, C, Marnitz, S, Hallek, M, Diehl, V, Dietlein, M & Engert, A 2021, ' PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial ', The Lancet Oncology, vol. 22, no. 2, pp. 223-234 . https://doi.org/10.1016/S1470-2045Test(20)30601-X
Strahlentherapie Und Onkologie

مصطلحات موضوعية: Male, medicine.medical_treatment, Medizin, Procarbazine, Gastroenterology, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Medicine, 030212 general & internal medicine, 610 Medicine & health, Etoposide, education.field_of_study, Middle Aged, Combined Modality Therapy, Hodgkin Disease, Dacarbazine, Treatment Outcome, Oncology, Vincristine, 030220 oncology & carcinogenesis, Female, Rituximab, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Population, Vinblastine, Disease-Free Survival, Bleomycin, Young Adult, 03 medical and health sciences, Internal medicine, Mucositis, Humans, education, Cyclophosphamide, Neoplasm Staging, Proportional Hazards Models, Chemotherapy, business.industry, medicine.disease, Regimen, ABVD, Doxorubicin, Positron-Emission Tomography, Prednisone, business, Literatur Kommentiert

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f13d466acfe65ac8d5c77ff231c4382Test
https://doi.org/10.1016/s1470-2045Test(20)30601-x

4

Early Response to First-Line Anti–PD-1 Treatment in Hodgkin Lymphoma: A PET-Based Analysis from the Prospective, Randomized Phase II NIVAHL Trial

المؤلفون: Paul J Bröckelmann, Bastian von Tresckow, Christian Baues, Peter Borchmann, Helen Goergen, Michael Fuchs, Markus Dietlein, Horst Müller, Jasmin Mettler, Andrea Kerkhoff, Ulrich Keller, Andreas Engert, Conrad-Amadeus Voltin, Carsten Kobe, Stephanie Sasse, Lutz van Heek, Karolin Trautmann-Grill, Julia Meissner

المصدر: Clinical Cancer Research. 27:402-407

مصطلحات موضوعية: Adult, Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Dacarbazine, Medizin, Vinblastine, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Outcome Assessment, Health Care, Humans, Medicine, Doxorubicin, Prospective Studies, Immune Checkpoint Inhibitors, Chemotherapy, business.industry, Middle Aged, medicine.disease, Hodgkin Disease, Survival Analysis, 3. Good health, Lymphoma, Radiation therapy, Nivolumab, 030104 developmental biology, Positron-Emission Tomography, 030220 oncology & carcinogenesis, Concomitant, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb5b1929ac4963afc27a78f6b16b1f73Test
https://doi.org/10.1158/1078-0432.ccr-20-3303Test

5

Histopathological growth patterns in patients with advanced nodular lymphocyte-predominant Hodgkin lymphoma treated within the randomized HD18 study : A report from the German Hodgkin Study Group

المؤلفون: Peter Borchmann, Andreas Rosenwald, Ina Bühnen, Martin-Leo Hansmann, Wolfram Klapper, Bastian von Tresckow, Andreas Engert, Michael Fuchs, Peter Möller, Dennis A. Eichenauer, Helen Goergen, Sylvia Hartmann, Alfred C. Feller, Stefanie Kreissl, Heinz-Wolfram Bernd

وصف الملف: application/octet-stream

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8abdc45b77ad5760367b866ffb7ef522Test
https://www.ncbi.nlm.nih.gov/pubmed/34396513Test

6

Rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: long-term follow-up of a phase 2 study from the German Hodgkin Study Group

المؤلفون: Bastian von Tresckow, Peter Borchmann, Michael Fuchs, Sylvia Hartmann, Andreas Engert, Martin-Leo Hansmann, Annette Plütschow, Boris Böll, Dennis A. Eichenauer

المصدر: Leukemia. 34:953-956

مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, business.industry, Long term follow up, Phases of clinical research, Hematology, Newly diagnosed, Gastroenterology, language.human_language, German, Oncology, Nodular Lymphocyte Predominant Hodgkin Lymphoma, Internal medicine, medicine, language, Rituximab, Stage (cooking), business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::abada5ad2dfcc370d2157ae69cd7ca58Test
https://doi.org/10.1038/s41375-019-0609-3Test

7

Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14)

المؤلفون: Peter Borchmann, Richard Greil, Volker Diehl, Josée M. Zijlstra, Jana Markova, Julia Meissner, Sarah Gillessen, Andreas Engert, Max S. Topp, Annette Plütschow, Dennis A. Eichenauer, Bastian von Tresckow, Michael Fuchs, Paul J Bröckelmann

المساهمون: Hematology, CCA - Cancer Treatment and quality of life

المصدر: Gillessen, S, Plütschow, A, Fuchs, M, Markova, J, Greil, R, Topp, M S, Meissner, J, Zijlstra, J M, Eichenauer, D A, Bröckelmann, P J, Diehl, V, Borchmann, P, Engert, A & von Tresckow, B 2021, ' Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14) ', The Lancet Haematology, vol. 8, no. 4, pp. e278-e288 . https://doi.org/10.1016/S2352-3026Test(21)00029-6
The Lancet Haematology, 8(4), e278-e288. Lancet Publishing Group

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57cfeea8e46362c19db45e3507629e0bTest
https://research.vumc.nl/en/publications/c1e461ac-5125-4d24-8c7e-10b59a9ac174Test

8

Gene expression-based outcome prediction in advanced stage classical Hodgkin lymphoma treated with BEACOPP

المصدر: Leukemia
Leukemia, 35(12):35893593

مصطلحات موضوعية: 0301 basic medicine, BEACOPP, Oncology, Male, Cancer Research, Receptor, Platelet-Derived Growth Factor alpha, Letter, CD30, medicine.medical_treatment, Medizin, 610 Medizin, 0302 clinical medicine, Gene expression, Antineoplastic Combined Chemotherapy Protocols, polycyclic compounds, Cancer microenvironment, Hodgkin lymphoma, Etoposide, ddc:610, Hematology, Middle Aged, Hodgkin Disease, Survival Rate, Treatment Outcome, Vincristine, 030220 oncology & carcinogenesis, Cohort, Female, Risk assessment, medicine.drug, Adult, medicine.medical_specialty, Adolescent, Ki-1 Antigen, macromolecular substances, PDGFRA, 03 medical and health sciences, Bleomycin, Young Adult, Predictive Value of Tests, Internal medicine, medicine, Humans, Cyclophosphamide, Neoplasm Staging, business.industry, Gene Expression Profiling, Gene expression profiling, 030104 developmental biology, ABVD, Doxorubicin, Procarbazine, Prednisone, Chemokine CCL17, business, Transcriptome

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad6c3d13abb506896b7cd2eaa18a823Test
https://pubmed.ncbi.nlm.nih.gov/34112956Test

9

Treatment patterns and disease course of previously untreated Primary Central Nervous System Lymphoma : Feasibility of MTX-based regimens in clinical routine

المؤلفون: Hyatt Balke-Want, Peter Borchmann, Jan-Michel Heger, Noëlle Sieg, Florian Simon, Sarah Gillessen, Bastian von Tresckow, Paul J Bröckelmann, Martina Deckert, Jan-Hendrik Naendrup, Stefanie Kreissl, Philipp Gödel

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lymphoma, Medizin, Salvage therapy, Aggressive lymphoma, Central Nervous System Neoplasms, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Germany, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Humans, Medicine, Practice Patterns, Physicians', Aged, Aged, 80 and over, Performance status, business.industry, Primary central nervous system lymphoma, Hematology, General Medicine, Middle Aged, Prognosis, Clinical routine, medicine.disease, Combined Modality Therapy, Survival Analysis, Clinical trial, Methotrexate, Treatment Outcome, 030220 oncology & carcinogenesis, Retreatment, Female, Rituximab, business, 030215 immunology, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb616389740ff14f11f93153e97a1995Test
https://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&origin=inward&scp=85106433338Test

10

Pembrolizumab monotherapy in patients with primary refractory classical hodgkin lymphoma who relapsed after salvage autologous stem cell transplantation and/or brentuximab vedotin therapy: KEYNOTE-087 subgroup analysis

المؤلفون: Margaret A. Shipp, Bastian von Tresckow, Pier Luigi Zinzani, Akihiro Tomita, Robert T. Chen, Vincent Ribrag, Nathalie A. Johnson, Akash Nahar, Arun Balakumaran, John Radford, Theodoros P. Vassilakopoulos, Philippe Armand, Daniel Molin, Craig H. Moskowitz, Jianxin Lin, Pauline Brice

المساهمون: Zinzani, Pier Luigi, Chen, Robert, Armand, Philippe, Johnson, Nathalie A, Brice, Pauline, Radford, John, Ribrag, Vincent, Molin, Daniel, Vassilakopoulos, Theodoros P, Tomita, Akihiro, von Tresckow, Bastian, Shipp, Margaret A, Lin, Jianxin, Nahar, Akash, Balakumaran, Arun, Moskowitz, Craig H

المصدر: Leuk Lymphoma

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Immunoconjugates, medicine.medical_treatment, Subgroup analysis, macromolecular substances, Pembrolizumab, Antibodies, Monoclonal, Humanized, Transplantation, Autologous, Article, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Refractory, immune system diseases, hemic and lymphatic diseases, Internal medicine, polycyclic compounds, Classical Hodgkin lymphoma, medicine, Humans, Brentuximab vedotin, Brentuximab Vedotin, Salvage Therapy, Chemotherapy, business.industry, Hematopoietic Stem Cell Transplantation, food and beverages, Hematology, Hodgkin Disease, 030220 oncology & carcinogenesis, Pembrolizumab, hodgkin lymphoma, autologous stem cell transplantation, brentuximab vedotin, Neoplasm Recurrence, Local, business, Chemoradiotherapy, Stem Cell Transplantation, 030215 immunology, medicine.drug

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cdccc5f1260187842b7dc141a02cd8eTest
http://hdl.handle.net/11585/737037Test

تنقيح النتائج